Apparatus and method of stimulating elevation of glutathione levels in a subject

• US 9,149,451 B1
• Filed: 12/09/2013
• Issued: 10/06/2015
• Est. Priority Date: 05/15/2008
• Status: Active Grant

• Current Assignee: Soletluna Holdings, Inc.
• Original Assignee: LifeWave, Inc.
• Inventors: Schmidt, David G.
• Primary Examiner(s): Navarro, Albert
• Assistant Examiner(s): Portner, Ginny
• Application Number:
  US14/101,046
• Time in Patent Office: 666 Days
• Field of Search: 424/449, 424/400, 424/468, 424/424, 424/444, 514/400
• US Class Current: 1/1
• CPC Class Codes: A61K 31/198 Alpha-amino acids, e.g. alanine or edetic acid [EDTA] betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00
• CPC Class Codes: A61K 38/063 Glutathione
• CPC Class Codes: A61K 9/0014 Skin, i.e. galenical aspects of topical compositions non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00
• CPC Class Codes: A61N 2/02 using magnetic fields produced by coils, including single turn loops or electromagnets A61N2/12 takes precedence
• CPC Class Codes: A61N 2005/0645 Applicators worn by the patient
• CPC Class Codes: A61N 2005/0659 infrared
• CPC Class Codes: A61N 2005/0661 ultraviolet
• CPC Class Codes: A61N 2005/0665 Reflectors

Abstract

An apparatus configured to provide a beneficial biological effect for a subject, and/or a method of treating the subject using the apparatus. The apparatus may be configured to trigger and maintain the elevation of Glutathione levels within the subject. The apparatus may rely on a non-invasive mechanism to elevate Glutathione levels in the subject. The apparatus may not require a traditional power source such as a battery or wall plug in order to be effective in elevating Glutathione levels in the subject. To trigger and maintain the elevation of Glutathione levels within the subject, the apparatus may transmit communication to the body of the subject that results in increased levels of Glutathione within the subject.

Claims

1. A method of treating a subject, the method comprising:

elevating Glutathione levels by a therapeutically effective amount by affixing an apparatus to the subject such that the apparatus remains at or near the skin of the subject for a prolonged period of time, wherein the apparatus comprises;

(A) one or more substrates;

(B) a chemical mixture disposed on or about the one or more substrates, the chemical mixture including one or more natural amino acids, wherein if the one or more substrates and the chemical mixture are brought proximate to the subject without directly contacting the subject, the proximity of the one or more substrates and the chemical mixture to the subject trigger and maintain an increase in Glutathione levels in the body of the subject; and

(C) an enclosure that surrounds the one or more substrates and the chemical mixture and is configured to prevent the one or more substrates and/or the chemical mixture from coming into direct contact with and entering the body of the subject.

2. The method of claim 1, wherein the chemical mixture comprises Glutathione.

3. A method of treating a subject, the method comprising:

treating a subject suffering from a Glutathione mediated condition including one or more of a pulmonary disease, a degenerative brain condition, a viral infection, a burn injury, acute pancreatitis, an immune dysfunction, exposure to a chemical weapon, an effect of mercury exposure, or diabetes by elevating Glutathione levels in the subject to a therapeutically effective level by affixing an apparatus to the subject such that the apparatus remains at or near the skin of the subject for a prolonged period of time, wherein the apparatus comprises;

(D) one or more substrates;

(E) a chemical mixture disposed on or about the one or more substrates, the chemical mixture including one or more natural amino acids, wherein if the one or more substrates and the chemical mixture are brought proximate to the subject without directly contacting the subject, the proximity of the one or more substrates and the chemical mixture to the subject trigger and maintain an increase in Glutathione levels in the body of the subject; and

(F) an enclosure that surrounds the one or more substrates and the chemical mixture and is configured to prevent the one or more substrates and/or the chemical mixture from coming into direct contact with and entering the body of the subject.

4. The method of claim 3, wherein the chemical mixture comprises Glutathione.

5. The method of claim 3, wherein treating the subject suffering from a Glutathione mediated condition including one or more of a pulmonary disease, a degenerative brain condition, a viral infection, a burn injury, acute pancreatitis, an immune dysfunction, or diabetes comprises treating the subject for side effects of another treatment administered to the subject for one or more of a pulmonary disease, a degenerative brain condition, a viral infection, a burn injury, acute pancreatitis, an immune dysfunction, or diabetes.

6. The method of claim 3, wherein treating the subject for one or more of a pulmonary disease, a degenerative brain condition, a viral infection, a burn injury, acute pancreatitis, an immune dysfunction, or diabetes comprises elevating the Glutathione levels within the body of the subject.